Hinderer, Christian,Wilson, James M.,Wilson, Matthew
申请号：
AU2016302335
公开号：
AU2016302335A1
申请日:
2016.08.05
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Compositions and methods for treating type II diabetes in a subject. A viral vector is provided which includes a nucleic acid molecule comprising a sequence encoding a propeptide and the active portion of GLP-1, wherein, when expressed, the N-terminal amino acid of GLP-1 immediately follows the C-terminal amino acid of the propeptide. In desired embodiments, the subject is a cat or dog.
